News about "Series A Financing "

Vedana Therapeutics Launches with USD 46 Million Series A Financing for Migraine Therapies

Vedana Therapeutics Launches with USD 46 Million Series A Financing for Migraine Therapies

Vedana Therapeutics has launched with USD 46 million in Series A financing to advance next-generation migraine therapies. Backed by migraine experts and investors, the company is developing innovative treatments targeting clinically validated pathways to help patients achieve lasting freedom from migraine.

Series A Financing | 17/06/2026 | By News Bureau

AltrixBio Raises USD 5 Million Series A Financing and Appoints David Pass as CEO

AltrixBio Raises USD 5 Million Series A Financing and Appoints David Pass as CEO

Dr David Pass, a veteran of the pharma, biotech, and medical device sectors with a track record of scaling programs to over USD 1 billion in sales, succeeds AltrixBio Co-Founder and CEO Nancy Briefs, who led the company from inception and will now serve as Executive Chair.

Series A Financing | 18/09/2025 | By Dineshwori 383

Abselion Secures EUR 6.6 Million in Series A Financing

Abselion Secures EUR 6.6 Million in Series A Financing

Abselion will use the funds to drive the commercialisation and expand the capabilities of its Amperia system.

Series A Financing | 12/12/2024 | By Aishwarya 251

Allink Biotherapeutics Secures USD 42 Million Series A Financing Round

Allink Biotherapeutics Secures USD 42 Million Series A Financing Round

The financing round was led by Lanchi Ventures, a preeminent global early-stage technology investor known for backing breakthrough innovations, with participation from an elite syndicate of new investors.

Series A Financing | 02/12/2024 | By Aishwarya 220

Myricx Bio Secures EUR 90 Million in Series A Financing

Myricx Bio Secures EUR 90 Million in Series A Financing

Myricx Bio has raised EUR 90 Million (USD 114 Million) in the latest Series A financing round.

Series A Financing | 08/07/2024 | By Aishwarya 522

YGION Biomedical Secures EUR 15 Million in Series A Financing for YGNITE

YGION Biomedical Secures EUR 15 Million in Series A Financing for YGNITE

The funds will be used to further develop YGION's innovative YGNITE™ technology platform and advance their lead program, YG-01, into preclinical and clinical stages.

Series A Financing | 21/05/2024 | By Abha 687


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members